sary cardiac testing in renal failure patients, while the enhanced sensitivity contributes to risk stratification Background. Non-specific elevations of creatine kinase isoenzymes (CK-MB) and cardiac troponin-T may be and aids in diagnosing true myocardial injury in this population susceptible to non-specific elevations in seen in renal failure, confusing the diagnosis of myocardial infarction. Cardiac troponin-I (cTn-I ) has other muscle enzymes. been shown to be specific for myocardial damage in Key words: end-stage renal disease; myocardial ischseveral disease states, but has not been prospectively aemia; renal failure; troponin-I evaluated in the setting of renal failure. Methods. This prospective case series evaluated 56 patients with acute or chronic renal failure or endstage renal disease to assess the sensitivity and specifi-Introduction city of cTn-I for detecting myocardial injury in this patient population. During a 6-month period, patients The conventional tools for diagnosing acute myocardadmitted with suspected myocardial injury by history, ial injury have been history and physical examination physical examination, and electrocardiography were in conjunction with 12-lead electrocardiography evaluated. Cardiac troponin-I (cTn-I ) measurements ( ECG), serial creatine kinase isoenzyme (CK and were assessed between 8 and 48 h after admission. CK-MB) measurements, and determination of lactate Appropriate medical care and further cardiac testing dehydrogenase (LDH ) isoenzyme ratios. Unfor-(echocardiography, stress testing, or arteriography) tunately, CK-MB assays can be misleading in renal was performed at the discretion of the primary failure due to non-specific enzyme elevations in 5-50% physician.
has not been prospectively evaluated in the setting of group and cTn-I negative group had evidence of myocardial ischaemia on follow-up testing. However, renal failure. Therefore this study investigated whether cTn-I is a more accurate predictor of myocardial injury a positive cTn-I was highly predictive of a positive diagnostic cardiac test in follow-up ( Table 1) . than CK-MB in patients with renal failure.
Twenty-one of 56 (38%) patients enrolled had indeterminate CK-MB results. Nine of these 21 had positive
Subjects and methods

cTn-I values. Of those with indeterminate CK-MB values, 53% (8/15) demonstrated myocardial ischaemia
Patients on follow-up testing, while six patients did not undergo further cardiac evaluation. Of patients with indetermin-A prospective, observational, case-series study was imple-ate CK-MB and positive cTn-I values, all had positive mented at an academic medical centre ( Vanderbilt University cardiac studies. Likewise, seven of eight (88%) with Medical Center) and an associated teaching hospital (St indeterminate CK-MB and negative cTn-I values had Thomas Hospital ). During a 6-month period, 56 patients negative studies.
with end-stage renal disease (ESRD), chronic renal failure Elevated cTn-I levels were associated with a signific-(CRF ), or acute renal failure (ARF ) admitted with a primary antly worse in-hospital prognosis, particularly among diagnosis of suspected myocardial injury were evaluated. The patients with CRF/ESRD. The mortality rate for study population consisted of equal numbers of males and females, with a mean age of 62 years. There were 24 African-patients with elevated cTn-I levels was 29% (4/14), Americans, 31 Caucasians, and one Asian; 50 patients with while only five of 33 (15%) of patients with normal CRF/ESRD and six patients with ARF. All patients except cTn-I levels died during hospitalization (P<0.001).
one had at least two co-morbid illnesses (hypertension, Sensitivity and specificity for CK-MB in this study diabetes, coronary artery disease or congestive heart failure, were respectively 44% (95% confidence interval, obstructive lung disease, peripheral vascular disease, or car-20-68%)and 56% (95% confidence interval, 32-80%). diac arrhythmias). All patients were evaluated by history, Values for cTn-I were much higher at 94% sensitivity physical examination, ECG, and serial CK with CK-MB (95% confidence interval, 82-106%) and 100% specifimeasurements. Each patient had one serum cTn-I determinacity. Positive and negative predictive values were exceltion between 8 and 48 h after admission. A positive cTn-I lent for both CK-MB (100 and 90% respectively) and level was defined as>0.8 ng/ml. CK-MB levels were considered positive when the total CK was elevated with an MB for cTn-I (100 and 94%), though CK-MB calculations fraction>5% while levels were negative when the MB fraction were confounded by the inclusion of the large 'indewas<5% (regardless of total ). CK-MB assays were consid-terminate' category. formed at the discretion of the patient's primary physician, indeterminate results [1, 2] . In this study we evaluated and a positive test was defined as demonstrating a new cTn-I as a marker for myocardial injury in patients cardiac abnormality (by echocardiography or nuclear with renal failure, and found it to be more sensitive imaging) or severe occlusive coronary artery disease (by and specific than CK-MB in this patient population. arteriography).
Moreover, the group of patients with indeterminate CK-MB values had a high incidence of cardiac abnorStatistical methods malities on follow-up cardiac testing, which were correctly predicted by cTn-I levels.
Test characteristics were calculated from data gathered on
Positive and negative CK-MB assays correlated well patients with available follow-up cardiac testing. Data are with positive and negative cTn-I assays. Positive and reported as percentages with 95% confidence intervals. negative cTn-I levels demonstrated little or no correlaStatistical comparisons between groups were performed with tion with CK-MB measurement due to the large a two-tailed t test or Chi square analysis where indicated. A number of indeterminate CK-MB values. Despite the P value less than 0.05 was considered statistically significant. high prevalence of ischaemic heart disease in the renal failure population, sensitivity and specificity for
Results
CK-MB are of limited value due to the large number of 'indeterminate' patients. Indeed, by designating a 'CK-MB indeterminate' category we have artificially The study cohort was contrasted by CK-MB or cTn-I and stratified according to diagnostic testing as shown enhanced the predictive values of positive and negative CK-MB categories. in Figure 1 . Myocardial injury was diagnosed in seven of 56 (13%) patients by standard CK-MB determinaElevated cTn-I levels were highly predictive of positive cardiac testing. In addition, elevated cTn-I measuretion, while 18/56 (32%) were positive by cTn-I testing. All patients with negative CK-MB were also cTn-I ments distinguished a group of patients with worse short-term prognosis, similar to that reported by Apple negative. One patient each in the CK-MB negative and Antman [15, 16 ] . It has been suggested that cTn-I be reasonable to consider cTn-I the rapid assay of choice for evaluating myocardial injury in the renal is significantly more sensitive than other muscle enzyme assays in distinguishing cardiac muscle damage of any failure population. This study is limited by its observational nature and aetiology, i.e. ischaemia, inflammation, or trauma [17] [18] [19] . It is possible that cTn-I elevations in the face the moderate amount of follow-up data used to calculate test characteristics. Additionally, because of the of normal CK-MB concentrations represented patients in an unstable phase of cardiac disease, and may have small population size, this study is subject to beta error. Yet it is important to recognize that ultimately identified patients who had sustained significant cardiac injury several days prior or in whom cardiac there is no 'gold standard' for determining the accuracy of positive and negative cardiac serodiagnostic injury was an ongoing phenomenon. The release kinetics of cTn-I have led to the proposal that current cTn-I markers. We included three forms of cardiac evaluation, each with strengths, weaknesses, and the posassays replace LDH isoenzymes in evaluating subacute myocardial injury [20] . Given the calculated sensitivity sibility of false positives and negatives. The method of cardiac evaluation was determined by the primary of cTn-I in this study and the known false positive or indeterminate rate inherent to CK-MB assays, it may physician or consulting cardiologist, recognizing the 
